From Personality To Property: Data Protection Needs Competition & Consumer Protection Law, Conference Says 25/10/2016 by Monika Ermert for Intellectual Property Watch 1 Comment MUNICH — Will personal data become a property right licensed to those who give you the best deal for it? Researchers at a conference convened by the Max Planck Institute for Innovation and Competition in Munich delved into a future “holistic approach” of intellectual property, data and consumer protection, with additional assistance from competition law.
US Copyright Office: Pallante Resigns; Search On For New Register [Updated] 24/10/2016 by Intellectual Property Watch 3 Comments The United States Copyright Office Register of Copyrights Maria Pallante has changed roles to become senior advisor for digital strategy. In her place, Karyn Temple Claggett will move up to serve as acting register of copyrights while a search is conducted for the next permanent register.
US High Court Puts Unreasonable Delay On Trial 21/10/2016 by Steven Seidenberg for Intellectual Property Watch Leave a Comment On its face, the case is a humdrum, procedural dispute about a patentee’s delay in filing an infringement suit. But if the Supreme Court rules the way most experts expect, the decision will significantly enhance the power of patent trolls and others alleging patent infringement, and it will harm many companies doing business in the US – especially companies in the tech sector. Much hangs in the balance on 1 November, when the Supreme Court hears oral arguments in SCA Hygiene Products AG v. First Quality Baby Products, LLC.
US, India Trade Ministers Agree List Of IP Enforcement Actions For India, USTR Says 20/10/2016 by William New, Intellectual Property Watch Leave a Comment United States Trade Representative Michael Froman and Indian Minister of Commerce and Industry Nirmala Sitharaman met in Delhi today and discussed various bilateral issues including intellectual property rights. Based on the release from the meeting, it appears much of the IP focus was on tasks for India to do to better protect IP rights.
Citizens’ Summit Contra CETA: It’s Not Only Wallonia 20/10/2016 by Intellectual Property Watch 1 Comment With the vote on the European Union-Canada trade agreement (CETA) on the agenda once more at the upcoming EU Council meeting tomorrow the representatives of European and Canadian cities and regions gathered at Brussels today for a “CETA Citizens’ Summit.” Gerardo Pisarello, vice mayor of the city of Barcelona, said that cities like his see CETA as a barrier to their plans to remunicipalize water and energy services and the attempts “to open up public procurement to small companies and cooperatives.”
Trump Silence On IP Policy Leaves Rights Owners Baffled 20/10/2016 by Dugie Standeford for Intellectual Property Watch 18 Comments While US Democratic presidential candidate Hillary Clinton has published detailed positions on intellectual property, technology transfer and trade, Republican candidate Donald Trump has limited his comments to trade reform and alleged Chinese IP theft. The policy vacuum has left the IP community not only uncertain of Trump’s intentions but unable even to find the right people to ask, one IP attorney said. [Note: story updated with a comment about IP made by Trump]
The Comments Are In On South African IP Framework; Action Seen In Early 2017 20/10/2016 by Linda Daniels for Intellectual Property Watch 1 Comment The invitation by the South African Department of Trade and Industry (DTI) to intellectual property stakeholders to comment on its recently released IP Consultative Framework has reignited calls for the department to come clean on the status of the national draft IP policy.
Indian Company Moves To Provide Affordable Insulin Biosimilar In Europe As Patents Rise 19/10/2016 by Tatum Anderson for Intellectual Property Watch Leave a Comment Bangalore-based Biocon may become the first Indian company to offer a biosimilar insulin in Europe. And the patent and pricing story is interesting.
Nearly 100 Organisations Press For Better Medicines Access In Asian Region RCEP Agreement 19/10/2016 by William New, Intellectual Property Watch Leave a Comment Nearly 100 health, community and development organisations working in the Asia-Pacific region issued a call for trade ministers negotiating the Regional Comprehensive Economic Partnership (RCEP) trade agreement to “reject provisions that would negatively affect access to generic medicines.” Negotiators are meeting from 17-22 October in China, and the concern is about the intellectual property chapter of the deal.
Eli Lilly Commits To Healthcare For 30 Million People In Middle-Income Countries And US By 2030 18/10/2016 by Intellectual Property Watch Leave a Comment Pharmaceutical manufacturer Eli Lilly today announced a stepped-up commitment to provide improved access to quality healthcare for 30 million people in resource-limited settings by 2030.